UK-CAB 61: HIV and primary care

Friday 20 January 2017

DRAFT Programme

09.30-09.40 Arrival, tea and refreshments
09.40-10.00 Welcome and introductions, UK-CAB updates, Company pre-meeting (Simon Collins to lead)
10.00-11.30 Company meeting: Gilead Sciences 
11.30-11.45 BREAK
11.45-12.30 Feedback on Gilead, Conferences feedback
12.30-14.00 LUNCH
14.00-15.15 Invited speakers:

  1. Primary care for HIV patients – Dr Richard Ma, GP, Islington
  2. Primary care study – Dr Maryam Shahmanesh, Mortimer Market Centre
15.15-16.00 Community reps feedback:

  1. BHIVA Sexual and Reproductive Health Guidelines – Chris O’Connor
  2. BHIVA Audit and Standards Subcommittee feedback – Ben Cromarty
16.00-16.10 BREAK
16.10-16.55 Reflection and feedback of the meeting; member updates
16.55 AOB
17.00 Meeting close

 Presentations from this meeting:

Getting the most out of your general practitioner – Dr Richard Ma

Shared care: Findings from the BHIVA primary care project Dr Maryam Shahmanesh

BHIVA SHR guidelines on assisted conception Chris O’Connor

BHIVA Audit and Standards subcommittee feedback – Ben Cromarty

Background reading:

HPV vaccine – for gay men, trans and HIV+ in England – update
Gay men and transgender people in England now have limited access to the HPV vaccine. Early results from an ongoing pilot study are extremely encouraging.

After years of community campaigning for the NHS to provide equity of care to gay men, the first data show that the vaccine is easy to deliver with a high level of interest in uptake. Limited data on the pilot programme were presented in a small informal briefing by Public Health England (PHE) who manage the programme

Read full article by Simon Collins here.
Download the PHE leaflet here.

Factsheet: GPs and primary care
This factsheet highlights the contribution which general practice doctors (usually called GPs or family doctors), and other NHS services termed ‘primary care services’ can make to the care of people with HIV.

What do people with HIV expect from primary care?
Results from any online survey of PLWHIV. This was present at the BHIVA meeting on HIV and primary care.

How GPs should approach HIV testing
Article by Dr Richard Ma in Pulse

Managing common medical conditions, co-morbidities, drug interactions
Presentation from the BHIVA meeting on HIV and primary care.

Primary care practice still fails to diagnose HIV patients from high-risk groups or with symptomatic acute infection
This is a conference report on a presentation by Dr Fiona Burns from the Royal Free and UCL Medical School These are results from a survey of almost 290 recently diagnosed African patients, attending 14 London HIV clinics, between April 2004 and February 2006.

MEDFASH – HIV in primary care
This is the European version booklet provides essential information on HIV for GPs, practice nurses and other members of the primary healthcare team. The booklet provides information on: HIV and the consequences of infection; the clinical diagnosis of HIV in primary care; HIV testing and prevention strategies in primary care and the management of those with HIV – with a primary care focus. Section 2 of this booklet on How to diagnose HIV in primary care and includes PrEP.

Primary care an overview of issues
This is a rather long report but there’s an interesting and concise Overview of Issues – pages 5-7. The longer sections are interesting too, on: access; being listened to and a safe, dignified and quality service.

 Videos:

The role of the GP – 6.24min
The video of Dr Hannah Warren (née Lambert) records her experiences as a GP.

Transformations in primary care  5.24min
Dr Amir Hannan talks at a King’s Fund event about the benefits of giving patients access to their full GP electronic health records, and about how this works at Haughton Thornley Medical Centres where over 3,000 patients have access.

Financial support

The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.

The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.

We believe that manufacturers who currently develop and market medicines have a responsibility to actively engage with advocacy organisations and that HIV positive people and their advocates should be able to directly question manufacturers about the safety and efficacy of their products and proposals for future research.

For a list of companies that support the UK-CAB please see the “about us” page.

Edit
Published: January 24, 2017
Last edited: May 25, 2017